Conmed (CNMD) Capital Expenditures Growth (1y) (2011 - 2026)
Powered by 
Analysis
Conmed (CNMD) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -6.52% |
| 10 | Conmed | 1.48 Bn | 1.44 Bn | 197.46 Mn | -48.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.79% |
| Mar 31, 2026 | -23.47% |
| Dec 31, 2025 | 26.51% |
| Sep 30, 2025 | 51.71% |
| Jun 30, 2025 | 59.58% |
| Mar 31, 2025 | 85.70% |
| Dec 31, 2024 | -16.79% |
| Sep 30, 2024 | -36.61% |
| Jun 30, 2024 | -20.73% |
| Mar 31, 2024 | -52.16% |
| Dec 31, 2023 | -14.46% |
| Sep 30, 2023 | -19.62% |
| Jun 30, 2023 | -20.70% |
| Mar 31, 2023 | 15.38% |
| Dec 31, 2022 | 78.04% |
| Sep 30, 2022 | 20.38% |
| Jun 30, 2022 | 90.75% |
| Mar 31, 2022 | 18.59% |
| Dec 31, 2021 | 1.24% |
| Sep 30, 2021 | 69.61% |